Prodrugs of aza nucleosides based on proton transfer reaction
Author:
Publisher
Springer Science and Business Media LLC
Subject
Physical and Theoretical Chemistry,Computer Science Applications,Drug Discovery
Link
http://link.springer.com/content/pdf/10.1007/s10822-010-9389-6.pdf
Reference57 articles.
1. The Leukemia & Lymphoma Society (2001) Myelodysplastic syndrome. White Plains, NY
2. Wijermans P, Lübbert M, Verhoef G et al (2000) Low-dose 5-aza-2’-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol 18:956–962
3. Silverman LR, Demakos EP, Peterson BL et al (2002) Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 20:2429–2440
4. Silverman LR, McKenzie DR, Peterson BL et al () Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B. J Clin Oncol 2006(24):3895–3903
5. Kantarjian H, Issa JP, Rosenfeld CS et al (2006) Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 106:1794–1803
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enzyme Models—From Catalysis to Prodrugs;Molecules;2021-05-28
2. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review;Drug Metabolism Reviews;2021-01-02
3. Prediction the ability of using vitamins and amino acids as carrier’s linkage for diclofenac drug: A theoretical and comparative approach;Results in Chemistry;2021-01
4. Theoretical Study to Predict the Ability to Use Different Organic Substituents as Carrier Linkages for Diclofenac;Asian Journal of Chemistry;2021
5. Taste Masking Approaches for Medicines;Current Drug Delivery;2018-02-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3